| EPIC |
HLN |
| Sector |
Pharma and Biotech |
| ISIN |
GB00BMX86B70 |
| Market Sector |
MAIN |
| Market Segment |
SET1 |
| Main Indices |
FTSE 100, FTSE 350, FTSE All-Share |
| Country of register |
Great Britain |
| Currency |
British Pound |
| Market Cap |
£29,381m |
| NMS |
7,500 |
| Shares in issue |
8,797m |
| Date Listed |
n/a |
| |
Interim |
Final |
| Ex-Div |
13-Aug-26 |
09-Apr-26 |
| Paid |
17-Sep-26 |
14-May-26 |
| Amount |
2.40p |
4.90p |
| 16:38 |
3,015 @ 334.00p |
| 16:38 |
11,259 @ 334.00p |
| 16:38 |
5,035 @ 334.00p |
| 16:38 |
6,224 @ 334.00p |
| 16:38 |
16,888 @ 334.00p |
| CEO |
Brian McNamara |
| Chair |
Manvinder Singh (Vindi) Banga |
| CFO |
Dawn Allen |
Top of Page
You are here:
research